FDA “Delayering” Initiative Reorganizes Office of Commissioner
This article was originally published in The Gray Sheet
Executive Summary
The Center for Devices & Radiological Health already meets FDA's agency-wide "delayering" goals and will likely be exempted from further restructuring, according to device center staffers